08.02.21 Monthly Special Edition: Water Management
By 3M Separation and Purification Sciences Division
Brewing beer is both an art and a science. Beer needs to taste good, but it also must look good, be protected from spoilage, and come from a brewing process that’s reliable and efficient, minimizing product waste to maximize what gets into the bottle.
(0)
ST. PAUL, Minn., June 1, 2021 /PRNewswire/ 3M Health Care launched 3M Harvest RC clarifier, leveraging its proprietary fibrous chromatography media to deliver a single-stage purification solution for recombinant protein therapeutic manufacturing. It is the next generation in harvest and clarification technology and is designed as an efficient option to increase monoclonal antibody (mAb) yields while streamlining a traditionally multi-stage harvest clarification process into a single stage. As cell culture processes are intensified to yield higher cell densities and product titers, the ability to effectively harvest the cell culture fluid with the consistency and scalability required becomes challenging, said Dr. Alexei Voloshin, global application development manager, 3M Separation and Purification Sciences. The 3M Harvest RC clarifier is an innovative solution that combats these challenges while eliminating several steps to improve the biopharmaceutical purification proce
Share this article
Share this article
ST. PAUL, Minn., June 1, 2021 /PRNewswire/ 3M Health Care launched 3M™ Harvest RC clarifier, leveraging its proprietary fibrous chromatography media to deliver a single-stage purification solution for recombinant protein therapeutic manufacturing. It is the next generation in harvest and clarification technology and is designed as an efficient option to increase monoclonal antibody (mAb) yields while streamlining a traditionally multi-stage harvest clarification process into a single stage.
3M™ Harvest RC clarifier introduces chromatography technology to the harvest process enabling single-stage clarification of high-density cell culture fluid resulting in robust soluble and insoluble contaminant separation and high product recovery.
By the end of this week, the world should cross two small but significant milestones on the road to overcoming COVID-19 getting at least 5% of the global population fully vaccinated against SARS-CoV-2, with at least 10% receiving one dose of vaccines that require two. The worldwide march toward vaccination explains why this year is expected to be as good as it gets when it comes to the size of the market for COVID-19 vaccines and drugs. The first authorized drugs and vaccines indicated for COVID-19 generated more than a combined $10.91 billion in sales during the first quarter of 2021 more than double the $4.23 billion generated all of 2020.
Distributed Manufacturing Can Stabilize Biopharma Production
Over the past two decades, the supply chains of drug manufacturing companies have become longer, more intricate, and increasingly fragmented. In fact, supply chain complexity was identified as a root cause of drug shortages in a report released in 2019 and updated last year by the interagency Drug Shortage Task Force, which is run by the FDA. [Andrew Brookes / Cultura / Getty Images]
3M describes how biopharma manufacturers can enhance supply chain security in the age of COVID-19 and beyond
May 3, 2021
Over the past two decades, the supply chains of drug manufacturing companies have become longer, more intricate, and increasingly fragmented. In fact, supply chain complexity was identified as a root cause of drug shortages in a report released in 2019 and updated last year by the interagency Drug Shortage Task Force, which is run by the FDA. [Andrew Brookes / Cultura / Getty Images]